ATRA vs CHTR · rev $128.9M vs P/E 11, rev $55.09B
Atara Biotherapeutics Inc (ATRA) versus Charter Communications Inc (CHTR) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
Charter Communications Inc (CHTR) is a telecom services company listed on US.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported CHTR revenue for 2024-12-31 was $55.09B. Net income was $5.85B. Revenue was up 0.9% from 2023-12-31 to 2024-12-31. CHTR currently screens at market cap $56.24B and trailing P/E 11.5.
ATRA currently screens at market cap $87.1M. CHTR currently screens at market cap $56.24B and trailing P/E 11.5.
Not investment advice. Open the ATRA and CHTR stock pages for the full models.
Not investment advice.